Home›Companies›Biotech & Pharma›Pairidex

Pairidex Inc.

Updated Oct 27, 2026·Latest SEC filing Feb 20, 2025·Suggest an edit

About Pairidex

Pairidex is a private company based in St. Louis, Missouri, incorporated in 2023 in Delaware. It has reported $1,090,000 raised in one offering on Form D since February 2025. Its chief executive is Andrew Young.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 15, 2024Feb 20, 2025$1,090,000fully sold16$68,125Debt, Options, Securities on exerciseRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Pairidex's Form D filed Feb 20, 2025.

TD
Todd Druley
Director
AM
Allyson Mayer
Chief Operating Officer
AY
Andrew Young
Director; Chief Executive Officer

Sources

  1. SECPairidex Inc. filing history